Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02241967 · ClinicalTrials.gov registry record · Phase 1
Dose Dependent Effects of tDCS on Post-Operative Pain
A Phase 1 study, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- Phase 1
- Development phase
- 119
- Enrollment target
NCT02241967: Completed Phase 1 study, sponsored by VA Office of Research and Development.
NCT02241967 is a Phase 1 study that has completed, run by VA Office of Research and Development. The registered enrollment target is 119 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02241967, a Phase 1 study, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 119 participants
- Enrollment target
Study Summary
The proper control of acute and chronic pain is one of the most important areas in health care. Despite the profound advances in neuroscience over the past 20 years, the investigators still largely use opiate narcotics, much as was done in the Civil War. Total knee arthroplasty (TKA) is one of the most common orthopedic procedures performed 1. While knee pain is often a complaint that precedes TKA, the procedure itself is associated with considerable post-operative pain lasting days to weeks. Adequate postoperative pain control is an important factor in determining recovery time and hospital length of stay. New analgesic strategies are needed that can be used adjunctively to existing strategies with the potential to reduce reliance on opioid analgesia. Several novel brain stimulation technologies including transcranial magnetic stimulation (TMS) and transcranial direct current stimulation (tDCS) are beginning to demonstrate promise as treatments for a variety of pain conditions. Electricity has no metabolite or other residue, and can be delivered with minimal discomfort and without problems associated with drug-drug interactions. In two independent preliminary pilot studies, the Investigators have shown that tDCS can reduce post-operative PCA use by as much as 46% while simultaneously reducing subjective pain ratings. The present study aims to determine the effects of transcranial direct current stimulation (tDCS) on post-operative pain, patient-controlled analgesia (PCA) use, and post-surgical complications during the 48-hour post-operative period following total knee arthroplasty.
Interventions
- DEVICE Sham Transcranial Direct Current Stimulation
- DEVICE 4 Real sessions of Transcranial Direct Current Stimulation
- DEVICE 2 Real Sessions of Transcranial Direct Current Stimulation
- DEVICE 1 Real Session of Transcranial Direct Current Stimulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 119 participants |
| Start Date | 2016-01-07 |
| Est. Completion | 2020-07-02 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02241967
The ClinicalTrials.gov registry entry for NCT02241967 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 119 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Sham Transcranial Direct Current Stimulation is the first listed.
NCT02241967 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02241967 about?
NCT02241967 is a clinical study titled "Dose Dependent Effects of tDCS on Post-Operative Pain". The proper control of acute and chronic pain is one of the most important areas in health care. Despite the profound advances in neuroscience over the past 20 years, the investigators still largely use opiate narcotics, much as was done in the Civil War. Total knee arthroplasty (TKA) is one of the m...
What is the current status of trial NCT02241967?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 119 participants. The study started on 2016-01-07. Estimated completion is 2020-07-02.
What interventions are being tested in trial NCT02241967?
The interventions under investigation include: Sham Transcranial Direct Current Stimulation (DEVICE), 4 Real sessions of Transcranial Direct Current Stimulation (DEVICE), 2 Real Sessions of Transcranial Direct Current Stimulation (DEVICE), 1 Real Session of Transcranial Direct Current Stimulation (DEVICE).
Who is sponsoring clinical trial NCT02241967?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.